SCHEMBL4466852

SCHEMBL4466852

CCc1ccc(Oc2cccc3c2C(=O)c2cccc(Oc4ccc(CC)cc4)c2C3=O)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNA3 P22001 1/20 0.43
▸ EGFR P00533 1/20 0.43
▸ PIM1 P11309 1/20 0.43
▸ ELANE P08246 2/20 0.43
▸ ALDH1A1 P00352 3/20 0.42
▸ MAPT P10636 3/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ F2 P00734 1/20 0.42
▸ VDR P11473 1/20 0.42
▸ GAPDH P04406 1/20 0.42
▸ RAB9A P51151 3/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ NPC1 O15118 2/20 0.41
▸ LMNA P02545 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ ADORA2A P29274 1/20 0.41
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ TTR P02766 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10927218 0.79 ADORA2A (0.60) KCNA3EGFRPIM1ALDH1A1MAPT
SCHEMBL4471567 0.78 CES2 (0.49) KCNA3EGFRPIM1ALDH1A1MAPT
SCHEMBL21816994 0.77 CES2 (0.53) KCNA3EGFRPIM1ALDH1A1MAPT
SCHEMBL11110221 0.77 CES2 (0.53) KCNA3EGFRPIM1ELANEALDH1A1
SCHEMBL4477009 0.77 ADORA2A (0.50) KCNA3EGFRPIM1ALDH1A1MAPT
SCHEMBL8509039 0.77 ELANE (0.45) KCNA3ELANE
SCHEMBL1764840 0.76 ADORA2A (0.66) KCNA3EGFRALDH1A1MAPTKDM4E
SCHEMBL8508544 0.76 ELANE (0.46) KCNA3ELANE
SCHEMBL28598504 0.76 KCNA3 (0.67) KCNA3ELANEMAPTRAB9ASMN1; SMN2
SCHEMBL10583717 0.75 ADORA2A (0.55) KCNA3EGFRPIM1ELANEMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7494721-B2 Light-emitting device, condensed polycyclic compound used therein and method for producing same NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2009-02-24 — — US disclosed
US-20060051612-A1 Light-emitting device, condensed polycyclic compound used therein and method for producing same NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2006-03-09 — — US disclosed
EP-1589089-A1 LIGHT-EMITTING DEVICE, CONDENSED POLYCYCLIC COMPOUND USED THEREIN AND METHOD FOR PRODUCING SAME Nippon Kayaku Kabushiki Kaisha (JP) 2005-10-26 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060051612-A1 Light-emitting device, condensed polycyclic compound used therein and method for producing same CYBA, SCO2, NQO1 KCNA3 575/4885EGFR 3781/4885PIM1 1993/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback